# Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis

> **NCT02048085** · PHASE4 · WITHDRAWN · sponsor: **Medical Center of South Arkansas**

## Conditions studied

- Acute ST Segment Elevation Myocardial Infarction
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02048085
- **Lead sponsor:** Medical Center of South Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01-02
- **Primary completion:** 2015-05
- **Final completion:** 2018-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to get study up and enrolling
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048085, "Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02048085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*